MATRIX METALLOPROTEINESES AND THEIR TISSUE INHIBITORS IN PRIMARY BONE TUMOR PATIENTS: CLINICAL AND PATHOLOGIC CORRELATIONS
Introduction. The search of molecular markers for early diagnostics, prognosis, and identification of new objects for molecular-targeted therapy of primary bone tumors remains one of the most important tasks despite the significant achievements in the treatmen…